Search Results 411-420 of 19340 for B cell lymphomas
... cell lymphomas and Hodgkin's lymphomas. Focus areas. Prognostic markers ... B-cell lymphoma, Hodgkin's lymphoma and recipients of CAR-T therapy. Graft ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
B-cell lymphoma · Burkitt lymphoma · Follicular lymphoma · Hodgkin lymphoma; Non-Hodgkin lymphoma. Procedures performed · CAR-T cell therapy · Interests. Non- ...
CAR-T cells lose their potency. CAR-T cell therapy is an emerging treatment for blood cancers, putting some B-cell lymphomas and leukemias into complete ...
... B-cell lymphoma (rrDLBCL) in up to 138 participants from multiple sites. During an initial Dose Evaluation phase (first 2 cycles) to determine Dose Limiting ...
This trial may help find out if this approach is better or worse than the usual approach for treating peripheral T-cell lymphoma. Participation eligibility.
... cell therapy at Mayo Clinic. This research also is published in Blood. Improving response rates for CAR-T cell therapy in B cell lymphoma. “In CAR-T cell ...
A practical approach to FISH testing for MYC rearrangements and brief review of MYC in aggressive B-cell lymphomas. J Hematopathol. 2020; 13(3):127-135 ...
B-cell lymphoma · Follicular lymphoma · Leukemia · Lymphoma · Myelodysplastic syndromes · Procedures performed · Bone marrow transplant · CAR-T cell therapy ...
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS. Br J Haematol. 2025 Sep; 207 (3):1011-1018 Epub 2025 July 22. View PubMed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.